HomeCompareSHWGF vs SBUX

SHWGF vs SBUX: Dividend Comparison 2026

SHWGF yields 3.85% · SBUX yields 2.75%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SBUX wins by $41.5K in total portfolio value· pulled ahead in Year 7
10 years
SHWGF
SHWGF
● Live price
3.85%
Share price
$0.52
Annual div
$0.02
5Y div CAGR
38.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$116.0K
Annual income
$38,332.89
Full SHWGF calculator →
SBUX
SBUX
● Live price
2.75%
Share price
$89.59
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$157.5K
Annual income
$65,840.13
Full SBUX calculator →

Portfolio growth — SHWGF vs SBUX

📍 SBUX pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSHWGFSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SHWGF + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SHWGF pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SHWGF
Annual income on $10K today (after 15% tax)
$326.92/yr
After 10yr DRIP, annual income (after tax)
$32,582.96/yr
SBUX
Annual income on $10K today (after 15% tax)
$233.40/yr
After 10yr DRIP, annual income (after tax)
$55,964.11/yr
At 15% tax rate, SBUX beats the other by $23,381.15/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SHWGF + SBUX for your $10,000?

SHWGF: 50%SBUX: 50%
100% SBUX50/50100% SHWGF
Portfolio after 10yr
$136.8K
Annual income
$52,086.51/yr
Blended yield
38.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

SHWGF
No analyst data
Altman Z
2.6
Piotroski
6/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+16.1% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SHWGF buys
0
SBUX buys
0
No recent congressional trades found for SHWGF or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSHWGFSBUX
Forward yield3.85%2.75%
Annual dividend / share$0.02$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR38.1%48.3%
Portfolio after 10y$116.0K$157.5K
Annual income after 10y$38,332.89$65,840.13
Total dividends collected$87.0K$127.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: SHWGF vs SBUX ($10,000, DRIP)

YearSHWGF PortfolioSHWGF Income/yrSBUX PortfolioSBUX Income/yrGap
1$11,231$531.15$11,107$407.21+$124.00SHWGF
2$12,787$769.94$12,512$626.87+$275.00SHWGF
3$14,814$1,131.40$14,366$978.69+$448.00SHWGF
4$17,542$1,691.67$16,929$1,557.50+$613.00SHWGF
5$21,356$2,585.53$20,658$2,543.80+$698.00SHWGF
6$26,913$4,062.45$26,406$4,302.22+$507.00SHWGF
7← crossover$35,405$6,607.64$35,877$7,622.00$472.00SBUX
8$49,102$11,218.96$52,741$14,352.64$3.6KSBUX
9$72,621$20,081.68$85,676$29,243.03$13.1KSBUX
10$116,037$38,332.89$157,513$65,840.13$41.5KSBUX

SHWGF vs SBUX: Complete Analysis 2026

SHWGFStock

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers vascular and non-vascular access infusion devices, infusion sets, syringes, puncture needles, and specialized single-use clinical collection kits; wound sutures, wound healing dressings, and wound cleaning and nonvascular catheter supporting extracorporeal devices; and blood collection, storage, separation, and sterilization equipment. It also provides prefilled syringes and pre-filled flush syringes; blood collection and blood glucose testing devices; and general anesthesia consumables, local anesthesia consumables, anesthesia auxiliary consumables, ICU equipment, and open and minimally invasive surgical equipment. In addition, the company engages in the production and sale of orthopedic devices; tumor and blood vessel interventional instruments; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; industrial automatic equipment and parts; molds; hemodialysis equipment; and type I, type II, and type III medical devices. Further, it is involved in the finance leasing and factoring business; wholesale of type I medical devices, surgical devices, and other disposal medical products; provision of asset management, enterprise consulting, enterprise management advisory services, as well as logistics and storage services, as well as export its products. The company offers its products under the Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing brands. It serves hospitals, blood stations, and other medical units; and distributors. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.

Full SHWGF Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this SHWGF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SHWGF vs SCHDSHWGF vs JEPISHWGF vs OSHWGF vs KOSHWGF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.